|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/20 | |
| A61K 47/48 |
| (11) | Patento numeris | 2066336 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07867161.7 |
| Europos patento paraiškos padavimo data | 2007-09-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-06-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-09-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/020871 |
| Data | 2007-09-27 |
| (87) | Numeris | WO 2008/054585 |
| Data | 2008-05-08 |
| (30) | Numeris | Data | Šalis |
| 848326 P | 2006-09-28 | US | |
| 915603 P | 2007-05-02 | US |
| (72) |
OFT, Martin, US
SHEPPARD, Catherine, US
MUMM, John, US
LINGLING, Wu, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | USE OF PEGYLATED IL-10 TO TREAT CANCER |
| USE OF PEGYLATED IL-10 TO TREAT CANCER |